Showing 2371-2380 of 2972 results for "".
- Neuvian Skincare Granted US Patent for Dual-Peptide Complexhttps://modernaesthetics.com/news/neuvian-skincare-granted-us-patent-for-dual-peptide-complex/2483373/Neuvian Skincare has received a US patent for its dual-peptide formulation targeting inflammatory skin conditions such as wounds, scars, and eczema, according to a press release. The patent (No. 12,377,156 B2), issued for “Compositions and Methods for Treatment of Wounds and Inflammatory Skin Con
- Study Links Personality Traits to Rhinoplasty Satisfactionhttps://modernaesthetics.com/news/study-links-personality-traits-to-rhinoplasty-satisfaction/2483320/A new study published in Aesthetic Plastic Surgery suggests a distinct relationship between personality traits and satisfaction with rhinoplasty outcomes. The study, titled “Rhinoplasty and the ‘Big Five’ Model: The Impact of Patients’ Personality Traits on Post-surgical Satisfac
- Thermage® FLX Exceeds 5 Million Skin Tightening Treatmentshttps://modernaesthetics.com/news/thermage-flx-exceeds-5-million-skin-tightening-treatments/2483284/Solta Medical, a subsidiary of Bausch Health Companies Inc., announced that more than 5 million Thermage® treatments have been performed worldwide, underscoring the global uptake of its skin tightening technology. Thermage® uses monopolar radiofrequency energy to heat skin layers and stimu
- Revance Brings Mepivacaine-Based Fillers to US Markethttps://modernaesthetics.com/news/revance-brings-mepivacaine-based-fillers-to-us-market/2483155/Revance has announced the US launch of the Teoxane RHA® Collection with Mepivacaine, marking a significant innovation in dermal filler formulations. The update reflects a shift in anesthetic agents used in hyaluronic acid fillers, with mepivacaine replacing lidocaine as the primary ane
- Oral GLP-1 Hits Phase 3 Trial Targets; Regulatory Submissions Cominghttps://modernaesthetics.com/news/oral-glp-1-hits-phase-3-trial-targets-regulatory-submissions-coming/2483149/Eli Lilly and Company announced positive topline results from its Phase 3 ATTAIN-2 trial, showing that its investigational oral GLP-1 receptor agonist, orforglipron, achieved significant weight loss and improved cardiometabolic outcomes in adults with obesity or overweight status and type 2 diabe
- Device Manufacturer’s Initiative Offers Treatments to Support Firefighters’ Healthhttps://modernaesthetics.com/news/device-manufacturers-initiative-offers-treatments-to-support-firefighters-health/2483123/BTL Industries has launched a nationwide initiative aimed at addressing the mental and physical health challenges faced by firefighters, particularly those serving in high-risk wildfire regions. The program is framed under BTL’s Heros Deserve Healing campaign, which calls on clinicians an
- Innovative Hair Transplant Technique Combines MSCs to Enhance Hair Growthhttps://modernaesthetics.com/news/innovative-hair-transplant-technique-combines-mscs-to-enhance-hair-growth/2483096/New research published in Aesthetic Plastic Surgery reveals an innovative technique that may advance the treatment of baldness. In the article “Regenerative Hair Transplant: Innovation in Hair Transplantation Regenerative® Hair Transplant” the authors concluded that combining hair transp
- Korean Skincare Brand Launches in US with Sensitive-Skin Formulationshttps://modernaesthetics.com/news/korean-skincare-brand-launches-in-us-with-sensitive-skin-formulations/2483054/South Korean skincare brand Hexkin has entered the US market, offering products formulated for sensitive skin using collagen-based and peptide-driven technologies, according to a press release. Rooted in traditional Korean sk
- New Website Streamlines Laser Therapy Device Selectionhttps://modernaesthetics.com/news/new-website-streamlines-laser-therapy-device-selection/2482984/ColdLasers.org has launched LaserTherapy.com, a redesigned platform aimed at simplifying the process of selecting therapeutic laser devices. The site offers a modern interface, comparison tools, and updated educational content designed to support informed decision-making. The platform addr
- JUVÉDERM Day Returns with Limited-Time Offers Through Rewards Programhttps://modernaesthetics.com/news/juvederm-day-returns-limited-time-offers-through-rewards-program/2482957/Members of JUVÉDERM’s Alle loyalty rewards program will have an opportunity to purchase “buy one, get one” gift cards as part of JUVÉDERM Day on August 20, according to Allergan Aesthetics, an AbbVie company. Details of the exclusive, limited limited-time offers are as follows: •